mucopolysaccharide polysulphate
Small moleculeexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
1
Earliest trial started Nov 1, 2009 (NCT01226069)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Angiopoietin-1ACTIVATOR
ANGPT1 activator
- Tyrosine-protein kinase TIE-2ACTIVATOR
TEK activator
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109199 ↗
Also known as
- 2-acetamido-2-deoxy-d-galacto-d-glucuronoglycan polysulfate
- mps-polysulfate
- mucopolysaccharide polysulfate
- mucopolysaccharide polysulfate
- mucopolysaccharide polysulfate
- mucopolysaccharide polysulfuric acid ester
- mucopolysaccharide polysulphate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04534426 | Phase 4 | Dec 1, 2018 | Abant Izzet Baysal University |
| NCT01943006 | Phase 3 | May 1, 2015 | Medinova AG |
| NCT01203397 | Phase 3 | Sep 1, 2014 | EMS S/A, Medcin Instituto da Pele |
| NCT01426035 | Phase 3 | Sep 1, 2014 | EMS S/A, Medcin Instituto da Pele |
| NCT01226069 | N/A | Nov 1, 2009 | Nanyang Technological University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| EMS S/A | For profit | 2 | 2 | 1 | 2014 |
| Medcin Instituto da Pele | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Abant Izzet Baysal University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Medinova AG | For profit | 1 | 1 | 1 | 2015 |
| Nanyang Technological University | Academic/Hospital | 1 | 1 | 1 | 2009 |
5 organizations
Page 1 / 1